Airbus Helicopters has adopted a low-risk approach to expanding its light twin-engine rotorcraft offerings in a market that it already largely dominates. The company’s new H140—unveiled at the ...

The deal gives the Swiss pharma access to an experimental amylin-targeting treatment it will test in combination with drugs ...